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OBJECTIVE—Calcium-permeable cation channel TRPV2 is ex-
pressed in pancreatic -cells. We investigated regulation and
function of TRPV2 in -cells.
RESEARCH DESIGN AND METHODS—Translocation of
TRPV2 was assessed in MIN6 cells and cultured mouse -cells by
transfecting TRPV2 fused to green ﬂuorescent protein or TRPV2
containing c-Myc tag in the extracellular domain. Calcium entry
was assessed by monitoring fura-2 ﬂuorescence.
RESULTS—In MIN6 cells, TRPV2 was observed mainly in
cytoplasm in an unstimulated condition. Addition of exogenous
insulin induced translocation and insertion of TRPV2 to the
plasma membrane. Consistent with these observations, insulin
increased calcium entry, which was inhibited by tranilast, an
inhibitor of TRPV2, or by knockdown of TRPV2 using shRNA. A
high concentration of glucose also induced translocation of
TRPV2, which was blocked by nefedipine, diazoxide, and soma-
tostatin, agents blocking glucose-induced insulin secretion.
Knockdown of the insulin receptor attenuated insulin-induced
translocation of TRPV2. Similarly, the effect of insulin on TRPV2
translocation was not observed in a -cell line derived from islets
obtained from a -cell–speciﬁc insulin receptor knockout mouse.
Knockdown of TRPV2 or addition of tranilast signiﬁcantly inhib-
ited insulin secretion induced by a high concentration of glucose.
Likewise, cell growth induced by serum and glucose was inhib-
ited by tranilast or by knockdown of TRPV2. Finally, insulin-
induced translocation of TRPV2 was observed in cultured mouse
-cells, and knockdown of TRPV2 reduced insulin secretion
induced by glucose.
CONCLUSIONS—TRPV2 is regulated by insulin and is involved
in the autocrine action of this hormone on -cells. Diabetes 58:
174–184, 2009
I
nsulin elicits pleiotropic actions in a variety of target
cells and plays a pivotal role in regulating nutrient
metabolism. Recent studies have revealed that the
insulin signal is necessary to maintain the normal
function of pancreatic -cells. Thus, deletion of the insulin
receptor (IR) in -cells impairs insulin secretion and
results in glucose intolerance (1). In -cells of IRKO
mice, glucose-induced insulin secretion is reduced, which
is accompanied by reduction of the expression of GLUT2
and glucokinase (1). However, insulin secretion induced
by glyceraldehyde and KCl is also reduced in islets ob-
tained from a IRKO mouse (2), which cannot be ex-
plained simply by reduction of GLUT2 and/or glucokinase
expression. Because addition of anti-insulin antibody im-
mediately reduces insulin secretion from islets (3), it is
likely that insulin modiﬁes a molecule(s) involved in
insulin secretion by a nongenomic mechanism. In accor-
dance with these observations, knockdown of IR attenu-
ates glucose-induced insulin secretion in MIN6 cells (4). In
addition, postnatal -cell growth is impaired in IRKO
mice. Consequently, the mechanism by which insulin
maintains -cell function is not totally known at present. It
is thought that there must be a target molecule(s) of
insulin that regulates secretion and possibly growth of
-cells.
Transient receptor potential (TRP) (5) is a calcium-
permeable channel expressed in Drosophila. A large num-
ber of mammalian homologues have been identiﬁed, and
they regulate various cellular functions (6,7). Among them,
calcium-permeable cation channels resembling the va-
nilloid receptor channel (TRPV1) (8) have common fea-
tures and now are classiﬁed as members of the TRPV
subfamily (9). The TRPV subfamily consists of six mem-
bers, which function as cellular sensors responding to
changes in the temperature, osmolarity, and mechanical
stresses, and they are also regulated by various ligands (9).
TRPV2 is regulated by heat, growth factors, and other
ligands (10–13). An intriguing feature of TRPV2 is that its
intracellular localization is changed by various stimula-
tions. For example, IGF-I induces translocation of TRPV2
from an intracellular compartment to the plasma mem-
brane (11). Regarding its expression, TRPV2 is abundantly
expressed in neurons, neuroendocrine cells in the gastro-
intestinal tract, and blood cells such as macrophages (14).
In the pancreas, TRPV2 is expressed in -cells and ductal
cells. In this regard, we previously reported that TRPV2 is
expressed in an insulinoma cell line MIN6 (11). When
MIN6 cells are cultured in a serum-free condition, immu-
noreactivity of TRPV2 is localized in an intracellular
compartment. Addition of serum induces translocation of
TRPV2 to the plasma membrane (11).
In the present study, we further investigated regulation
of TRPV2 in -cells. Because these cells secrete insulin,
and the mode of action of insulin resembles that of IGF-I,
special attention was paid to the effect of insulin and
insulin secretagogues on the localization of TRPV2. The
results indicate that TRPV2 is regulated by insulin in an
autocrine manner in -cells. TRPV2 functions as an insu-
lin-mediated regulator of calcium entry.
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Materials. Bovine insulin, diazoxide, and ruthenium red (RuR) were pur-
chased from Sigma Chemical (St. Louis, MO). 1,2-Bis (o-aminophe-
noxy)ethane-N, N, N,N -tetraacetic acid tetra(acetoxymethyl) ester (BAPTA-
AM) and Dulbecco’s modiﬁed Eagle’s medium (DMEM) were obtained from
Invitrogen (Carlsbad, CA). D-()-Mannitol was obtained from Wako Pure
Chemical Industries (Osaka, Japan). Anti-Myc Tag (clone 9E10) monoclonal
IgG was obtained from Upstate (Lake Placid, NY) and anti-TRPV2 antibody
was from Biomol (Plymouth Meeting, PA). LY294002 was from Merck Calbio-
chem (Darmstadt, Germany). Somatostatin was purchased from the Peptide
Institute (Osaka, Japan). [
3H]Thymidine was obtained from Amersham
(Backs, U.K.), and fura-2 was from Dojindo (Kumamoto, Japan). Tranilast was
provided by Kissei Pharmaceuticals (Matsumoto, Japan).
Cell culture. Mouse MIN6, IRKO, and control WT cells (1,15) were
maintained in DMEM containing 25 mmol/l glucose and 15% fetal bovine
serum (FBS) at 37°C under a humidiﬁed atmosphere containing 5% CO2. CHO
cells were cultured in DMEM containing 10% FBS.
Islets were isolated from Balb/c mice by pancreatic duct injection of
collagenase solution followed by digestion (16). Isolated islets were dispersed
by incubation in 0.5 mmol/l EDTA-containing Hank’s balanced salt solution
(HBSS). Isolated cells were cultivated in RPMI medium containing 10% FBS.
-Cells were identiﬁed by staining with anti-insulin antibody.
Extraction of RNA and RT-PCR. Total RNA was prepared using TRIzol
reagent (Invitrogen). cDNA was synthesized from total RNA using the
superscript ﬁrst-strand synthesis system (Invitrogen) and primed with appro-
priate gene-speciﬁc primers. The synthesized cDNA was added to the PCR
mixture containing platinum pfx DNA polymerase (Invitrogen) in the presence
of 5 and 3 gene-speciﬁc primers (11). Quantitative PCR was conducted in a
20-l reaction mixture containing SYBR Premix EX Tag (Takara Bio, Tokyo,
Japan) using an ABI PRISM 7500 sequence detection system (Applied Biosys-
tem). The oligonucleotide primers for mouse IR were purchased from Takara
Bio. Primers for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
mouse TRPV2 were 5-TGC CAC TCA GAA GAC TGT GG-3,5 -TTC AGC TCT
GGG ATG ACC TT-3,5 -TAC GGT CCT GCT CGA GTG TC-3, and 5-TGG
CTC TAA AAC CAC CAT GC-3. Reaction mixtures were incubated for an
initial denaturation at 95°C for 10 s, followed by 35 PCR cycles. Each cycle
consisted of 95°C for 5 s and 60°C for 34 s. The expression level of each mRNA
relative to that of GAPDH was calculated using a standard curve.
Preparation of recombinant adenovirus. The hTRPV2-ﬂag-EGFP, hTRPV2-
ﬂag-RFP, and hTRPV2-ﬂag-EGFP-c-myc were prepared as described previ-
ously (12). To prepare adenovirus vector, we ligated hTRPV2-ﬂag-EGF/RFP
into the Entry Vector (Invitrogen) according to the manufacturer’s instruc-
tions. Because the adenoviral expression of GFP was observed at 95% at a
multiplicity of infection (MOI) of 20, we infected recombinant adenovirus at
20 MOI, unless otherwise stated.
Construction of short-hairpin RNA expression. Three short-hairpin oligo-
nucleotides and complementary strands were designed to speciﬁcally target
mouse IR, and six oligonucleotides were designed to specially target mouse
TRPV2. The BLOCK-iT U6 RNAi Entry Vector Kit (Invitrogen) was used for
shRNA construction. To generate the recombinant adenovirus vectors ex-
pressing shRNAs for mouse IR (Ad-shIR) and mouse TRPV2 (Ad-shTRPV2),
selected pENTER/U6-shRNA plasmids were recombined into the Gateway-
based pAd-BLOCK-iT DEST vector (Invitrogen), according to the manufactur-
er’s instructions. As a negative control, adenovirus expressing shRNA against
LacZ (Ad-shLacZ) was generated. The sequences of effective IR-shRNA and
TRPV2-shRNA are shown below. Mouse IR-shRNA: top: 5caccGCAAGCTCT-
TCTTCCATTACAcgaaTGTAATGGAAGAAGAGCTTGC, bottom: 5aaaaaG-
CAAGCTCTTCTTCCATTACAttcgTGTAATGGAAGAAGAGCTTGC; Mouse
TRPV2-shRNA 1: top: 5caccGCTGGCTGAACCTGCTTTATTcgaaAATAAAG-
CAGGTTCAGCCAGC, bottom: 5aaaaaGCTGGCTGAACCTGCTTTATTttcgAA-
TAAAGCAGGTTCAGCCAGC.
Detection of TRPV2 incorporated into the plasma membrane. To mea-
sure TRPV2 incorporated in the plasma membrane, cells were transfected
with adenovirus vector containing c-myc–tagged TRPV2. Cells were seeded on
a noncoated glass coverslip at a density of 2  10
5/ml and incubated with
Krebs-Ringer bicarbonate buffer (KRB). For BAPTA loading, cells were
incubated with 10 mol/l BAPTA-AM in Ca
2-free KRB containing 2.5 mmol/l
glucose for 20 min before insulin stimulation. For immunostaining, cells were
not permeabilized, and c-myc epitope exposed outside was detected by using
anti–c-myc antibody (1:400). Diaminobenzidine was used as a chromogen.
Quantiﬁcation of the signal was done by using the National Institutes of Health
image.
Transfection of cells and measurement of translocation of TRPV2. Cells
were transfected with TRPV2-EGFP or c-myc–tagged TRPV2. After 24 h
incubation, cells were rinsed three times every hour in KRB buffer containing
5 mmol/l glucose. Before stimulation, cells were preincubated in KRB buffer
containing 2.5 mmol/l glucose for 30 min. To determine translocation of
TRPV2, ﬂuorescence images were recorded with an Olympus IX70 epiﬂuores-
cence microscope (Olympus, Tokyo, Japan) equipped with a PXL 1400 cooled
charge-coupled device camera system (Photometrics, Tucson, AR), which was
operated with IP Lab Spectrum software (Signal Analysis, Vienna, VA) and a
laser confocal microscope (LSM 510, Zeiss).
To assess translocation of TRPV2 semiquantitatively, we scored the
expression pattern of TRPV2 on the cell surface. When 30% of the margin of
the cell was positive for the TRPV2-GFP signal, the cell was considered to be
translocation positive. The measurement was done independently by two
researchers in a double-blinded manner.
Measurement of cytosolic free calcium concentration. Cytoplasmic free
calcium concentration ([Ca
2]c) was monitored using fura-2. The ratio of the
ﬂuorescence intensities for each of the excitation wavelengths (F340/F380)
was monitored using Aqua Cosmos (Hamamatsu Photonics, Hamamatsu,
Japan) (12). In Mn
2-quenching experiments, ﬂuorescence was obtained by
exciting at 360 nm. After fura-2 loading, cells were incubated in the presence
or absence of insulin for 20 min in KRB buffer containing 1.25 mmol/l calcium.
Then 100 mol/l MnCl2 was added to the solution, and the rate of Mn
2
quenching was monitored.
Measurement of [
3H]thymidine incorporation and cell number. Cells
were seeded at a density of 2  10
5 cells/ml in a 24-well dish. Twelve hours
after seeding, the cells were incubated for 4 h with serum-free DMEM
containing Ad-sh-LacZ or Ad-sh-mTRPV2. Infected cells were then cultured for
40 h with 15% FBS and 25 mmol/l glucose. The cells were then incubated in
DMEM containing 25 mmol/l glucose and 0.25 Ci [
3H]thymidine for 4 h. After
incubation, cells were washed twice with 1 ml ice-cold PBS and solubilized,
and radioactivity associated with trichloroacetic acid–precipitable material
was counted.
For measurement of the cell number, cells were seeded at a density of 2 
10
5 cells/ml in a 35-mm dish and were incubated for 4 h with serum-free
DMEM containing Ad-shLacZ or Ad-shTRPV2. Infected cells were then cul-
tured for various periods in medium containing 15% FBS and 25 mmol/l
glucose, and the cell number was counted.
Insulin secretion. Insulin release was measured by batch incubation. KRB
buffer supplemented with 0.1% BSA was used for the experiment. MIN6 cells
were seeded at a density of 2  10
5 cells/ml in a 24-well dish and cultured for
3 days. Dispersed mouse islet cells were cultured at a destiny of 5  10
4
cell/ml in a 24-well dish. After preincubation with 1 ml KRB for 30 min, cells
were then incubated in the presence of various stimulators for 60 min. The
medium was centrifuged at 15,000 rpm for 5 min, and the supernatant was
kept at 20°C until assay. Insulin secretion from permeabilized cells was
measured as described by Jones et al. (17). Insulin was determined using an
insulin radioimmunoassay kit (Eiken Chemical, Tokyo, Japan).
RESULTS
Expression of the TRPV family members in MIN6
cells. We ﬁrst examined the mRNA expression of the
TRPV family members in MIN6 cells. As shown in Fig. 1A,
mRNA for TRPV2 was detected in MIN6 cells, whereas
mRNA for other members of the TRPV family was not
detected in this condition.
Translocation of TRPV2 induced by serum in MIN6
cells. To investigate changes in the localization of TRPV2,
we transfected MIN6 cells with TRPV2-EGFP, and the GFP
ﬂuorescence was monitored. In most of the unstimulated
cells, the green ﬂuorescent protein (GFP) signal was
observed diffusely in cytoplasm (Fig. 1B, a). Addition of
serum-induced changes in the distribution of the GFP
signal and GFP was observed in the margin of the cells.
The effect of serum was observed within 15 min (Fig. 1B,
b) and persisted for at least 60 min (Fig. 1B, c). To
semiquantify the effect, we counted the number of cells
whose GFP signal was observed in the periphery of the
cell. As shown in Fig. 1C, addition of serum induced an
approximately threefold increase in the number of cells
whose GFP signal was observed in the periphery of the
cells. The effect of serum was inhibited by inhibitors of
phosphatidylinositol (PI) 3-kinase, LY294002 (Fig. 1C).
Effect of insulin on translocation of TRPV2 in MIN6
cells. The structure and function of the IGF-I receptor (18)
are quite similar to those of IR, and the two receptors
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speculated that insulin may reproduce the IGF-I effect, and
thus we addressed this possibility. Because MIN6 cells
secrete insulin, endogenous insulin released from these
cells may modify localization of TRPV2. We therefore
monitored GFP ﬂuorescence in cells cultured at low
density. As shown in Fig. 2A, insulin induced translocation
of TRPV2 to the plasma membrane. To conﬁrm the effect of
insulin on translocation, we determined colocalization of
the TRPV2-GFP signal with a plasma membrane marker
(PM) or an endoplasmic reticulum marker (ER). In the
absence of insulin, the TRPV2-GFP signal was observed in
cytoplasm. It was colocalized with ER (Fig. 2B, a) but not
with PM (Fig. 2B, b). In the insulin-stimulated cell, the GFP
signal was colocalized with PM (Fig. 2B, c).
We further examined whether TRPV2 was inserted into
the plasma membrane upon stimulation by insulin. To this
end, we transfected cells with c-myc–tagged TRPV2, and
cell surface c-myc was stained in intact cells. Even in the
absence of insulin, TRPV2 inserted into the plasma mem-
brane was observed to some extent (Fig. 2C, a). Addition
of insulin increased the amount of TRPV2 inserted into the
plasma membrane (Fig. 2C, b). Quantitative analysis indi-
cated that insulin signiﬁcantly increased immunoreactivity
of the c-myc tag (Fig. 2D). Note that immunoreactivity of
the c-myc tag in unstimulated cells was reduced by loading
BAPTA (Fig. 2D), a calcium chelator that reduced basal
secretion (Fig. 2E). Likewise, anti-insulin antibody signif-
icantly reduced basal c-myc immunoreactivity (Fig. 2D). A
similar experiment was done in CHO cells. In contrast to
MIN6 cells, c-myc immunoreactivity was quite low in
unstimulated CHO cells and was markedly increased after
the stimulation by serum (Fig. 2F).
Figure 3A shows the dose-response relationship for
insulin-induced translocation. This experiment was done
in cells loaded with BAPTA to reduce the basal transloca-
tion of TRPV2. As depicted, the effect of insulin was
detected at 500 pmol/l and was nearly maximal at 1 nmol/l.
As shown in Fig. 3B, the effect of insulin was observed 10
min after the stimulation and became maximal within 30
min. To assess the involvement of actin ﬁlament and
tubulin in insulin-induced translocation of TRPV2, we
examined the effects of latrunculin A and nocodazole,
respectively. As shown in Fig. 3C, TRPV2 translocation
was inhibited by latrunculin A but not by nocodazole.
Insulin-induced translocation of TRPV2 was blocked by a
dominantly negative mutant of Rac. Conversely, the effect
of insulin was reproduced by transfection of constitutively
Rac (Supplemental Fig. 1, found in an online appendix at
http://dx.doi.org/10.2337/dc08–0862). We also examined
the effect of endogenous insulin on translocation of
TRPV2. To this end, we stimulated the cells with a high
concentration of glucose. As shown in Fig. 3D, 25 mmol/l
glucose increased TRPV2 inserted into the plasma mem-
brane. This was not simply due to the increase in osmo-
larity, since 25 mmol/l mannitol did not show any effect.
The effect of glucose was inhibited by diazoxide. Similarly,
somatostatin blocked glucose-induced translocation. A
high concentration of potassium also induced insertion of
TRPV2 into the plasma membrane (Fig. 3E). Note that
nifedipine nearly completely blocked TRPV2 translocation
induced by a high concentration of glucose and potassium.
We then examined the translocation of endogenous TRPV2
using antibody recognizing the extracellular domain of
TRPV2. As shown in Fig. 3F, insulin increased the cell
surface expression of TRPV2. Likewise, high concentra-
tions of glucose and KCl increased cell surface expression
of TRPV2 (Fig. 3G).
We next addressed whether or not the effect of insulin
was mediated by IR. We decreased the expression of IR by
introducing shRNA. In cells infected with Ad-shIR, the
expression of IR was markedly reduced (Fig. 4A). Under
this condition, insulin was unable to induce translocation
of c-myc–TRPV2 on the cell surface (Fig. 4B, b). In
contrast, serum increased the expression of TRPV2 (Fig.
4B, c). Figure 4C shows quantitative analysis of the cell
surface expression of c-myc in IR knocked-down cells. We
also examined the effect of insulin in IRKO cells, a cell
line derived from -cells of IRKO mice. Insulin was
unable to increase the expression of c-myc-TRPV2 in the
plasma membrane (Fig. 4D, b; Fig. 4E, a), whereas serum
signiﬁcantly increased the cell surface expression of c-
myc–TRPV2 (Fig. 4D, c; Fig. 4E, a). Note that insulin
increased the expression of c-myc–TRPV2 in the plasma
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FIG. 1. Expression and translocation of TRPV2 in MIN6 cells. A:
Expression of the TRPV family members in MIN6 cells. Expression of
mRNA for various members of the TRPV family in MIN6 cells was
measured by RT-PCR. Note that primers used in this study are able to
detect mRNA for various members of the TRPV family (10,11). B: Effect
of serum on localization of TRPV2. MIN6 cells were transfected with
TRPV2-GFP using adenovirus vector, and the GFP ﬂuorescence was
measured. Cells were preincubated with serum-free medium for3ha n d
then incubated with 15% FBS for 15 min (b) and 60 min (c). Fluores-
cence images before (a) and after stimulation (b and c) are presented.
C: Semiquantitative analysis of the effect of serum. MIN6 cells trans-
fected with TRPV2-GFP were incubated for 15% FBS for 30 min in the
presence and absence of 50 mol/l LY294002. The number of cells in
which TRPV2 was located in the plasma membrane was counted in each
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4E, b).
Effect of insulin on calcium entry in MIN6 cells. To
examine the effect of insulin on calcium entry, we moni-
tored changes in [Ca
2]c using fura-2. Fura-2–loaded cells
were ﬁrst incubated in calcium-free medium, and then the
calcium in medium was elevated to 2 mmol/l. As shown in
Fig. 5A, an increase in [Ca
2]c was observed upon addition
of calcium. A similar experiment was done in the presence
of tranilast, an inhibitor of TRPV2 (20,21). A previous
study indicates that 75 mol/l tranilast markedly inhibited
IGF-I–induced calcium current (21). Tranilast inhibited the
elevation of [Ca
2]c in response to the addition of calcium.
When cells preincubated with insulin were treated in the
same manner, a large increase in [Ca
2]c was observed
after the addition of calcium (Fig. 5B), indicating that
insulin augmented calcium entry. Again, tranilast
markedly inhibited elevation of [Ca
2]c. We also measured
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FIG. 2. Effect of insulin on translocation of TRPV2 in MIN6 cells. A: Effect of exogenous insulin on translocation. MIN6 cells transfected with
TRPV2-GFP were preincubated with KRB buffer containing 2.7 mmol/l glucose for 1 h. They were then incubated with 10 nmol/l insulin for 30 min,
and ﬂuorescence images before (a) and after stimulation (b) are shown. B: Localization of TRPV2. a: Colocalization of TRPV2 with an ER marker.
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in insulin-stimulated cells. C: Effect of insulin on translocation of c-myc–tagged TRPV2. MIN6 cells transfected with c-myc–tagged TRPV2 were
preincubated with KRB buffer containing 2.7 mmol/l glucose for 1 h. They were then incubated for 30 min with (b) or without (a) 10 nmol/l insulin.
The c-myc epitope was stained in intact cells. Bar: 20 m. D: Quantiﬁcation of the immunoreactivity of c-myc epitope. MIN6 cells transfected with
c-myc–tagged TRPV2 were incubated for 30 min in various conditions, and cell surface expression of c-myc was quantiﬁed. Anti-Ins, anti-insulin
antibody. *P < 0.05 vs. none; **P < 0.01 vs. none. E: Effect of BAPTA loading on basal secretion of insulin. MIN6 cells loaded with or without
BAPTA were incubated for 60 min in the presence of 2.7 mmol/l glucose, and insulin secretion was measured. Values are the mean  SE for four
experiments. *P < 0.05 vs. control. F: Effect of serum on translocation of c-myc–tagged TRPV2 in CHO cells. CHO cells transfected with
c-myc–tagged TRPV2 were incubated for 30 min with (b) or without (a) 10% serum. The c-myc epitope was stained in intact cells. Bar: 20 m.
(Please see http://dx.doi.org/10.2337/db08-0862 for a high-quality digital representation of this ﬁgure.)
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concentration of potassium on translocation of TRPV2. MIN6 cells expressing c-myc–tagged TRPV2 were preincubated with KRB buffer containing 2.7
mmol/l glucose for 1 h. They were then incubated for 60 min with 40 mmol/l KCl in the presence and absence of 10 mol/l nifedipine (NF), and cell
surface expression of TRPV2 was quantiﬁed. Values are the means  SE for four experiments. **P < 0.01 vs. none, *P < 0.05 vs. KCl. F: Translocation
of endogenous TRPV2 in MIN6 cells. MIN6 cells were incubated for 20 min with (b) or without (a) 10 nmol/l insulin, and the cell surface expression
of TRPV2 was measured by staining intact cells with anti-TRPV2 antibody recognizing extracellular domain. G: Quantiﬁcation of translocation of
endogenous TRPV2. MIN6 cells were incubated for 20 min with 10 nmol/l insulin, 25 mmol/l glucose, or 40 mmol/l KCl, and the cell surface expression
of TRPV2 was quantiﬁed. Values are the mean  SE for ﬁve experiments. *P < 0.01 vs. none.
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Mn
2. Addition of Mn
2 into extracellular solution results
in a time-dependent entry of Mn
2 through calcium-
permeable channels. Once Mn
2 enters the cells, it re-
duces fura-2 ﬂuorescence. Consequently, the rate of
calcium entry is assessed by measuring the rate of quench-
ing of fura-2 ﬂuorescence. As shown in Fig. 5C, addition of
MnCl2 resulted in a time-dependent reduction of the fura-2
ﬂuorescence. This was due to entry of Mn
2 through
calcium-permeable channels. When cells were stimulated
by insulin, the rate of quenching was signiﬁcantly (P 
0.01) augmented (Fig. 5C). When a similar experiment
was done in the presence of tranilast, basal as well as
insulin-stimulated Mn
2 quenching was markedly re-
duced (Fig. 5D).
Effect of inhibition of TRPV2 on insulin secretion and
cell proliferation in MIN6 cells. We then examined the
role of TRPV2 in regulation of insulin secretion and cell
growth of MIN6 cells. We ﬁrst used an inhibitor of TRPV2.
As shown in Fig. 6A, tranilast did not affect basal secretion
but signiﬁcantly inhibited secretion induced by glucose.
Tranilast also signiﬁcantly inhibited insulin secretion in-
duced by a depolarizing concentration of potassium. To
rule out the possibility that tranilast nonspeciﬁcally inhib-
its exocytosis of insulin, we examined whether or not
tranilast affects insulin secretion induced by calcium using
permeabilized cells. As shown in Fig. 6B, tranilast did not
affect exocytosis of insulin induced by 10 mol/l calcium
in permeabilized cells. Tranilast also inhibited [
3H]thymi-
dine incorporation induced by FBS and a high concentra-
tion of glucose (Fig. 6C) and reduced the increase in the
cell number induced by FBS and a high concentration of
glucose (Fig. 6D). Note that tranilast does not inhibit DNA
synthesis induced by transfection of E2F, indicating that
this compound does not affect the machinery for DNA
replication (S. Nakajima, I.K., unpublished data). We also
examined the role of TRPV2 by reducing its expression
using shRNA. In MIN6 cells transfected with Ad-shTRPV2,
expression of mRNA for TRPV2 was markedly reduced
compared with that of cells transfected with Ad-shLacZ
(Fig. 7A). Similarly, Ad-shTRPV2 markedly reduced the
protein expression of TRPV2 (Fig. 7B). We then assessed
changes in calcium entry by measuring Mn
2 quenching.
In Ad-shTRPV2–infected cells, reduction of fura-2 ﬂuores-
cence induced by addition of Mn
2 was small (Fig. 7C, b)
compared with that in Ad-shLacZ–infected cells (Fig. 7C,
a). In addition, insulin did not increase the rate of Mn
2
quenching in Ad-shTRPV2–infected cells (Fig. 7C, b). We
then measured changes in [Ca
2]c in glucose-stimulated
Ad-shTRPV2–infected cells. [Ca
2]c ﬂuctuated consider-
ably at a later time point, and we could detect signiﬁcant
reduction of [Ca
2]c compared with that in Ad-shLacZ–
infected cells (Fig. 7D). Likewise, [Ca
2]c induced by 40
mmol/l KCl was signiﬁcantly reduced at a later time point
in Ad-shTRPV2–infected cells (data not shown). In this
condition, glucose-induced insulin secretion was signiﬁ-
cantly inhibited in Ad-shTRPV2–infected cells (Fig. 7F).
Likewise, insulin secretion induced by depolarizing con-
centration of potassium was signiﬁcantly reduced. Note
that the difference in insulin secretion was not due to the
difference in the cell number, since the cell number was
not changed in each condition. In addition, [
3H]thymidine
incorporation induced by serum and a high concentration
of glucose was signiﬁcantly reduced in cells infected with
Ad-shTRPV2 (Fig. 7G). Similarly, the increase in the cell
number induced by serum was reduced in Ad-shTRPV2–
infected cells compared with that of Ad-shLacZ–infected
cells (Fig. 7H). Cell viability was not changed and cell
death was not observed in Ad-shTRPV2–infected cells.
Role of TRPV2 in cultured mouse -cells. We studied
the expression of TRPV2 in mouse islets. As shown in Fig.
8A, TRPV2 was expressed in the core of the islet but not in
	-cells. Next, we studied the effect of insulin in cultured
-cells. When cultured -cells expressing c-myc–TRPV2
were incubated with 10 nmol/l insulin, immunoreactivity
of c-myc was increased signiﬁcantly after the insulin
treatment (Fig. 8B). Figure 8C shows the quantitative
analysis of the data. A high concentration of glucose also
induced translocation of TRPV2, which was blocked by an
addition of diazoxide. We then studied insulin secretion in
cultured -cells. In -cells infected with Ad-shTRPV2,
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glucose was signiﬁcantly reduced. Similarly, insulin secre-
tion induced by potassium was signiﬁcantly reduced in
Ad-shTRPV2–infected cells (Fig. 8D).
DISCUSSION
In this study, we showed that insulin induced transloca-
tion and insertion of TRPV2 into the plasma membrane.
Consistent with these observations, calcium entry as mon-
itored by fura-2 ﬂuorescence was elevated in cells pre-
treated with insulin, which was inhibited by an inhibitor of
TRPV2 and knockdown of TRPV2. Collectively, exogenous
insulin induces translocation of TRPV2 to the plasma
membrane and augments calcium entry. In our experimen-
tal condition, translocation of TRPV2 was observed to
some extent under basal conditions. This is in sharp
contrast to CHO cells and macrophages (12), where the
amount of TRPV2 in the plasma membrane is very low in
an unstimulated condition. This difference may be ex-
plained by the basal secretion of insulin, since the basal
level of translocation is reduced by loading BAPTA, which
reduces basal secretion, and by anti-insulin antibody.
These observations imply that translocation of TRPV2
induced by basal release of insulin may contribute to basal
calcium entry. Furthermore, translocation of TRPV2 was
induced by insulin secretagogues including a high concen-
tration of glucose. Taken together, insulin released from
-cells further augments calcium entry by recruiting
TRPV2 to the plasma membrane. Given that calcium is a
critical regulator of insulin secretion, this is a feed-forward
mechanism to accelerate insulin secretion. With regard to
the functional signiﬁcance of TRPV2, inhibition of the
TRPV2 activity by tranilast or by knockdown of TRPV2
using shRNA reduces glucose-induced insulin secretion.
Augmented calcium entry through TRPV2 may contribute
partly to glucose-induced insulin secretion. Also, TRPV2 is
involved in insulin secretion induced by other secreta-
gogues. For example, potassium-induced secretion is also
inhibited partly by inhibiting TRPV2. Presumably, insulin
released by depolarization of -cells in turn recruits
TRPV2 to the plasma membrane, which leads to additional
calcium entry through TRPV2 and thereby enhances insu-
lin secretion. It is known that voltage-dependent calcium
channels are downregulated (so-called inactivation) rather
quickly after depolarization of the plasma membrane. In
contrast, the TRPV2 channel is not downregulated quickly.
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180 DIABETES, VOL. 58, JANUARY 2009Instead, it promotes calcium entry for a relatively long
period (11). Consequently, recruitment of TRPV2 by insu-
lin may prolong calcium entry into -cells. TRPV2 is a
calcium-permeable channel and also permeates sodium as
well (11). Translocation of TRPV2 thus also increases
sodium entry into -cells. This leads to depolarization of
the plasma membrane and subsequent activation of the
voltage-dependent calcium channels. Recently, it was re-
ported that TRPM2 and TRPM4 are involved in glucose-
induced insulin secretion in pancreatic -cells (22,23).
TRPM2 and TRPM4 permeate calcium and/or sodium,
which leads to depolarization of the plasma membrane
and activation of the voltage-gated calcium channel. In
addition to the well-known role of the voltage-gated cal-
cium channels, members of the TRP channel family may
contribute to the stimulus-secretion coupling in -cells.
The autocrine effect of secreted insulin on -cell func-
tion has been a matter of debate. Both positive and
negative feedback regulations have been postulated, and
there have been many reports supporting these ideas (rev.
in 24). In this regard, a study using -cell–speciﬁc knock-
out of the IR gene demonstrated that blocking of the
insulin action in -cells impairs glucose-induced insulin
secretion and also reduces the -cell mass in adults (1).
The present results suggest that TRPV2 is one of the target
molecules of insulin and may participate at least partly in
the trophic action of this hormone in -cells. Inhibition of
the TRPV2 reduces insulin secretory response and DNA
0           2  4 
100   
10 
Time (day)
C
e
l
l
 
N
u
m
b
e
r
 
(
x
1
0
-
4
)
[
3
H
]
T
h
y
m
i
d
i
n
e
 
I
n
c
o
r
p
o
r
a
t
i
o
n
 
(
c
p
m
x
1
0
-
4
)
FBS (%)
 
1
2
Tranilast (µM)
1000
none Tranilast
500
4000
2000
I
n
s
u
l
i
n
 
(
µ
U
/
w
e
l
l
)
I
n
s
u
l
i
n
 
(
µ
U
/
w
e
l
l
)
Glucose (mM)
Tranilast (µM)
KCl (mM)
*
*
*
*
55
5
000 75 75 75
555 4 0 4 0
55 25 25
A
C
D
B
0 0 15 15
07 507 5
FIG. 6. Effect of tranilast on insulin secretion and proliferation in MIN6 cells. A: Effect of tranilast on insulin secretion. MIN6 cells were
preincubated with KRB buffer containing 2.7 mmol/l glucose for 30 min. They were then stimulated with 25 mmol/l glucose or 40 mmol/l KCl for
60 min in the presence and absence of 75 mol/l tranilast. Values are the mean  SE for four determinations, and the results are representative
of three experiments. *P < 0.05. B: Effect of tranilast on insulin secretion in permeabilized cells. Permeabilized MIN6 cells were incubated for
60 min with 10 mol/l calcium in the presence and absence of 75 mol/l tranilast. Insulin secretion in medium containing EGTA was subtracted.
Values are the mean  SE for four experiments. C: Effect of tranilast on [
3H]thymidine incorporation. MIN6 cells were incubated for 48 h with
or without 15% FBS and 25 mmol/l glucose in the presence and absence of 75 mol/l tranilast, and [
3H]thymidine in corporation was then
measured. Values are the mean  SE for four experiments. *P < 0.05. D: Effect of tranilast on the cell number. MIN6 cells were incubated for
various periods with 15% FBS and 25 mmol/l glucose in the presence (F) and absence (E)o f7 5mol/l tranilast. Values are the mean  SE for
three experiments, and the cell number was counted. *P < 0.05 vs. none.
E. HISANAGA AND ASSOCIATES
DIABETES, VOL. 58, JANUARY 2009 181synthesis in these cells. Given that stimulation of calcium
entry is a prerequisite for cell-cycle progression induced
by growth factors (25,26), it is likely that TRPV2 plays a
role in insulin-induced proliferation. Taken together,
TRPV2 functions as one of the molecular targets of the
insulin action and modulates calcium entry.
We studied the role of TRPV2 in MIN6 cells and dis-
persed -cells. It is uncertain at present whether or not
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TRPV2 CHANNEL IN PANCREATIC -CELLS
182 DIABETES, VOL. 58, JANUARY 2009insulin secreted from -cells actually controls transloca-
tion of TRPV2 in islet -cells in vivo. It is possible that
basal secretion of insulin induces translocation of TRPV2
and TRPV2 is always operative in the plasma membrane. It
is also possible that growth factors in plasma, for example
IGF-I, induces translocation and TRPV2 is always func-
tional. If so, insulin secretagogues do not regulate TRPV2
translocation. Instead, changes in the expression of
TRPV2, if any, would alter the basal rate of calcium entry.
Further studies are necessary to assess the in vivo role of
TRPV2 in -cells.
The present results provide for the ﬁrst time evidence
that calcium-permeable channel TRPV2 is a signaling
molecule involved in the insulin action. In this regard,
insulin is shown to recruit various types of ion channels to
the plasma membrane in neuronal cells (27–29). TRPV2 is
one of the channel molecules regulated by insulin. Many
issues are still unsolved. For example, it is not known
whether insulin directly modiﬁes gating of the TRPV2 in
addition to induction of translocation. Further studies are
necessary to elucidate the role of TRPV2 in the insulin
action.
ACKNOWLEDGMENTS
The present study was supported by a Grant-in-Aid for
Exploratory Research for the Ministry of Science, Educa-
tion, Sports and Culture of Japan (to I.K.); the Global COE
Program of Japan (to I.K.); and NIH Grant RO1 DK67536
(to R.N.K.).
No potential conﬂicts of interest relevant to this article
were reported.
The authors are grateful to Mayumi Odagiri for secre-
tarial assistance.
REFERENCES
1. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR:
Tissue-speciﬁc knockout of the insulin receptor in pancreatic  cells
creates an insulin secretory defect similar to that in type 2 diabetes. Cell
96:329–339, 1999
2. Otani K, Kulkarni RN, Baldwin AC, Krutzfeldt J, Ueki K, Stoffel M, Kahn
CR, Polonski KS: Reduced -cell mass and altered glucose sensing impair
insulin-secretory function in IRKO mice. Am J Physiol 286:E41–E49, 2004
3. Strivastava S, Goren HJ: Insulin constitutively secreted by -cells is
necessary for glucose-stimulated insulin secretion. Diabetes 52:2049–2056,
2003
4. Silva Xavier G, Qian Q, Cullen PJ, Rutter GA: Distinct roles for insulin and
insulin-like growth factor receptors in pancreatic -cell glucose sensing
revealed by RNA silencing. Biochem J 377:149–158, 2004
5. Montell CK, Jones K, Hafen E, Rubin G: Rescue of the Drosophlia
phototransduction mutation trp by germline transformation. Science 230:
1040–1043, 1985
6. Clapham DE: TRP channels as cellular sensors. Nature 426:517–524, 2003
7. Ramsey IS, Delling M, Clapham DE: An introduction to TRP channels. Ann
Rev Physiol 68:619–647, 2006
8. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D:
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
Nature 389:816–824, 1997
9. Gunthorpe MJ, Benham CD, Randall A, Davis JB: The diversity in the
vanilloid (TRPV) receptor family of ion channels. Trends Pharmacol Sci
23:183–191, 2002
10. Boels K, Glassmeier G, Herrmann D, Riedel B, Hampe W, Kojima I,
Schwartz JR, Schaller JR: The neuropeptide head activator induces acti-
vation and translocation of the growth-factor-regulated Ca
2-permeable
channel GRC. J Cell Sci 114:3599–3606, 2001
11. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I: Translocation
of a calcium-permeable cation channel by insulin-like growth factor-I. Nat
Cell Biol 1:165–170, 1999
12. Nagasawa M, Nakagawa Y, Tanaka S, Kojima I: Chemotactic factor
formyl-Met-Len-Phe induces translocation of TRPV2 in macrophage. J Cell
Physiol 210:692–702, 2007
ab
100
200
none
c
-
m
y
c
 
S
i
g
n
a
l
 
(
%
)
300
**
*
glucose glucose
+
diazoxide
*
0.1
0.2
I
n
s
u
l
i
n
 
(
%
 
o
f
 
I
n
s
u
l
i
n
 
C
o
n
t
e
n
t
)
0.3
0.4
0.5
*
*
Ad-shLacZ Ad-shTRPV2
Glucose (mM)
KCl (mM)
5
55 55 4 0 40
5 55 16.7 16.7
A
C
D
B
insulin
FIG. 8. Effect of insulin on TRPV2 translocation in mouse -cells. A:
Expression of TRPV2 in mouse islet. Mouse pancreatic section was
stained with anti-TRPV2 (red) and anti-glucose (green) antibodies. Nuclei
were stained with DAPI (blue). B: Effect of insulin on the cell surface
expression of c-myc epitope in cultured -cells. c-myc–TRPV2–expressing
cultured -cells were incubated with (b) or without (a) 10 nmol/l insulin
for 30 min, and intact cells were stained with anti–c-myc antibody. C:
Quantiﬁcation of the effect of insulin and glucose on TRPV2 translocation.
c-myc–TRPV2–expressing -cells were incubated for 60 min with various
agents, and cell surface c-myc TRPV2 was quantiﬁed. Values are the
mean  SE for four experiments. *P < 0.05 vs. none. **P < 0.05 vs.
glucose. D: Effect of Ad-shTRPV2 on insulin secretion from cultured
-cells. Cultured -cells were infected with Ad-shLacZ or Ad-shTRPV2.
Cells were preincubated for 30 min with KRB buffer containing 2.7 mmol/l
glucose. They were then incubated for 1 h with 16.7 mmol/l glucose or 40
mmol/l KCl, and insulin secretion was quantiﬁed. Data are means SE for
four experiments. *P < 0.05. (Please see http://dx.doi.org/10.2337/db08-
0862 for a high-quality digital representation of this ﬁgure.)
E. HISANAGA AND ASSOCIATES
DIABETES, VOL. 58, JANUARY 2009 18313. Stokes AJ, Shimoda LMN, Koblan-Huberson M, Adra CN, Turner H: A
TRPV2-PKA signaling module for transduction of physical stimuli in mast
cells. J Exp Med 200:137–147, 2004
14. Kowase T, Nakazato Y, Kuro-o Y, Morikawa A, Kojima I: Immunohisto-
chemical localization of growth factor-regulated channel (GRC) in human
tissues. Endocrine J 49:349–355, 2002
15. Kulkarni RN, Winnay JN, Daniels M, Bruning JC, Fleir SN, Hanahan D,
Kahn CR: Altered function of insulin receptor substrate-deﬁcient mouse
islets and cultured -cell line. J Clin Invest 104:R69–R75, 1999
16. Goto M, Maki T, Koizumi T, Satomi S Manaco AP: A improved method for
isolation of mouse pancreatic islet. Transplantation 40:437–438, 1985
17. Jones PM, Fyles JM, Howell SL: Regulation of insulin secretion by cAMP in
rat islets of Langerhans permeabilized by high-voltage discharge. FEBS
Lett 205:205–209, 1986
18. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel
W, Bon TL, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J,
Fujita-Yamaguchi Y: Insulin-like growth factor-I receptor primary struc-
ture. EMBO J 5:2503–2512, 1986
19. Czech M: Signal transmission by the insulin-like growth factors. Cell
59:235–238, 1989
20. Nie L, Ohnishi H, Doi I, Shibata H, Kojima I: Inhibition of proliferation of
MCF-7 breast cancer cells by a blocker of calcium-permeable cation
channel. Cell Calcium 22:75–82, 1997
21. Nie L, Kanzaki M, Shibata H, Kojima I: Activation of calcium-permeable
cation channel by insulin in Chinese hamster ovary cells expressing human
insulin receptors. Endocrinology 139:179–188, 1998
22. Cheng H, Beck A, Launay P, Gross SA, Stokes AJ, Kinet JP, Fleig A, Penner
R: TRPM4 controls insulin secretion in pancreatic  cells. Cell Calcium
41:51–61, 2007
23. Togashi K, Hara Y, Tominaga T, Higashi K, Konishi Y, Mori Y, Tominaga M:
TRPM2 activation by cyclic ADP-ribose at body temperature is involved in
insulin secretion. EMBO J 25:1804–1815, 2006
24. Leibiger IB, Leibiger B, Berggren PO: Insulin feedback action on pancre-
atic  cell function. FEBS Lett 532:1–6, 2002
25. Lu KP, Means AR: Regulation of the cell-cycle by calcium and calmodulin.
Endocrine Rev 14:40–58, 1993
26. Kojima I, Mogami H, Shibata H, Ogata E: Role of calcium entry and protein
kinase C in the progression activity of IGF-I in Balb/c 3T3 cells. J Biol
Chem 268:10003–10006, 1993
27. Wan Q, Xiong ZG, Man HY, Ackerley CA, Braunton J, Lu WT, Becker LE,
MacDonald JF, Wang YT: Recruitment of functional GABA receptors to
postsynaptic domains by insulin. Nature 388:686–690, 1997
28. Skeberdis VA, Lan J, Zheng X, Zukin RS, Bennett MV: Insulin promotes
rapid delivery of NMDA receptors to the cell surface by exocytosis. Proc
Natl Acad SciUSA98:3561–3566, 2001
29. Van Buren JJ, Bhat S, Rotello R, Pauza ME, Premkumar LS: Sensitization
and translocation of TRPV1 by insulin and IGF-I. Mol Pain 1:17–27, 2005
TRPV2 CHANNEL IN PANCREATIC -CELLS
184 DIABETES, VOL. 58, JANUARY 2009